Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | N-acetylaspartic acid | 693 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1142 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1279 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1335 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1355 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1633 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2080 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2299 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3067 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3114 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3231 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3793 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3875 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4163 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4530 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4612 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4737 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4798 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6063 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6148 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6357 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6622 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6802 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6825 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6902 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6970 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7001 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7041 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7386 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7725 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 8129 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 8424 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 8600 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 8695 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 9171 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 13371 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 14659 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 15364 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 15826 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 17103 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 17258 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 17834 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 19534 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 20650 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 25110 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 25185 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 26792 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 27244 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 28875 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 29203 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 31618 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 32512 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 33618 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 35316 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 35443 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 35967 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 36182 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 48966 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |